4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BioRestorative Therapies, Inc. (BRTX) operates in the Biotechnology industry and is headquartered in Melville, United States with about 13 employees. Its market capitalization is roughly $8 million. In the fiscal year ended 2025-12-31, BRTX reported $0M in revenue and ($14M) in net income.
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders.
Interactive charts & full statements → Open the BRTX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | — | — |
| Operating Income (EBIT) | ($16M) | ($12M) | ($15M) | ($19M) | — |
| Net Income | ($14M) | ($9M) | ($10M) | ($13M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($3M) | ($4M) | ($4M) | ($3M) | ($5M) |
| Net Income | ($2M) | ($3M) | ($3M) | ($3M) | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $4M | $12M | $13M | $16M | — |
| Total Liabilities | $4M | $4M | $3M | $6M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BRTX viewer.
About TickerBase · Data methodology & sources